Evidence map›Paper›PMID 39819409›Full record

ReviewCurrent neuropharmacology2025

Modulating Ferroptosis: A Novel Approach to Promote Neural Repair in Brain Injury.

Yanlin Liu, Ying Guo, Huixin Zhou, Yuxin Liu, Yuting Jin, Kaitao Luo, Xiaobing Dou

Abstract readReview
In one paragraph

Review in Current neuropharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yanlin LiuCollege of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
Ying GuoDepartment of Acupuncture and moxibustion, The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang 150001, China.
Huixin ZhouDepartment of Rehabilitation, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, Zhejiang 314033, China.
Yuxin LiuThird Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
Yuting JinThird Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
Kaitao LuoDepartment of Acupuncture and moxibustion, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, Zhejiang 314033, China.
Xiaobing DouCollege of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.

Funding

Basic Public Welfare Research Project of Zhejiang Province LGF20H270003Jiaxing City Science and Technology Bureau 2024AD30075Key Laboratory of Rehabilitation Study of Integrative Traditional Chinese and Western Medicine in Jiaxing City 2022[38]Scientific Research Project of the Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine 2023FSYYZQ15
6 · The paper itself

Abstract

The increasing prevalence of brain injuries resulting in cognitive and motor function impairments poses a substantial global medical challenge. Nerve repair therapies offer promise for addressing brain injury-related disorders. Ferroptosis, as a cell death mechanism associated with oxidative stress and inflammation. Certain ferroptosis inhibitors, such as iron chelators and antioxidants, exhibit therapeutic potential for brain injury-related conditions. This review explores the fundamental processes and associated mechanisms that regulate neural repair by inhibiting ferroptosis, thereby alleviating brain injury and promoting neuroregeneration. Furthermore, it examines the action mechanisms and potential therapeutic applications of ferroptosis inhibitors in neural repair, aiming to provide novel insights for treating brain injuries.

Indexed as

Brain InjuriesFerroptosisNerve RegenerationNeuroprotective AgentsAnimalsAntioxidantsHumansIron Chelating AgentsOxidative StressAntioxidantsIron Chelating AgentsNeuroprotective AgentsBrain injuryferroptosisferroptosis inhibitorsinflammationnerve repairneurodegeneration.

Identifiers

PMID39819409
PMCPMC12174948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.